A bit maybe like depression, right? Not everyone will respond to the same treatment [Alzheimer’s is] a very complex disease where maybe we could organize those patients in different categories to adapt a treatment better.

Marc Flajolet

Categorized in : Health

When new technologies were coming around we decided it was a good... by Marc Flajolet

When new technologies were coming around we decided it was a good time to try.

Most studies carried out till now were targeting the very late steps of this whole multi-step process, and we thought, ‘Let’s look at the very early steps and maybe we’ll have more chances to modulate this pathway,’ we found that was not only the case for amyloid plaques, but that it also worked in this animal model for memory.

For sure we have better treatments coming, they are not necessarily yet curing the disease, but they are really helping with many types of symptoms. The cure will be down the road. At this point it’s really just hard to tell if it’s going to take another five to seven years.

We know very well the expression ‘Time is money,’ i think in research it’s true as well, but I think in research it’s really the other way around— money is time. Really the more money we have, the more time we can save. And in this case, when we are racing against time for this disease, I think obviously the more money we have, the more we can do.